Test2

Boston Scientific (NYSE: BSX) has announced a limited market release of the WaveWriter Alpha™ portfolio of Spinal Cord Stimulator (SCS) systems. The unified portfolio of four MRI conditional, Bluetooth-enabled rechargeable and non-rechargeable implantable pulse generators (IPGs) provides uncompromised personalization, and for the first time in SCS, Fast Acting Sub-perception Therapy (FAST™) designed to deliver profound paresthesia-free pain relief in minutes.i The systems are supported by the Cognita™ Solutions suite of digital tools for patients and physicians.

Aaron Wang
China IS Lead
Amgen
A driven, versatile, innovative leader with extensive board experience, bringing extensive medical, regulatory and business acumen to global organizations.
LinkedInHome
Adar Pollack
VP Sales & Business Development
Humanostics Pte. Ltd.